Generics in China
- Pages: 34
- Published: January 2016
- Report Code: OHME4777
Generics in China industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the China generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
The Chinese generics market is expected to generate total revenues of $56.6bn in 2015, representing a compound annual growth rate (CAGR) of 18.3% between 2011 and 2015.
Market consumption volume is forecast to reach a total of 94.5 % of total pharma volume in 2015.
The Chinese government has announced an ambitious universal healthcare program that aims to provide healthcare for the country's 1.3 billion inhabitants. This should ensure further growth for the market.
Scope
Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in China
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in China
Leading company profiles reveal details of key generics market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the China generics market with five year forecasts by both value and volume
Macroeconomic indicators provide insight into general trends within the China economy
Reasons to buy
What was the size of the China generics market by value in 2015?What will be the size of the China generics market in 2020?
What factors are affecting the strength of competition in the China generics market?
How has the market performed over the last five years?
How large is China’s generics market in relation to its regional counterparts?
Companies mentioned
China Grand Pharmaceutical and Healthcare Holdings Limited, Mylan Inc., Sandoz International GmbH, Teva Pharmaceutical Industries Limited
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.